The MiningNewsWire Podcast

As consumers continue to insist on more healthy options in choices in their lives, the global health drinks market is projected to see consistent, continued growth, with a CAGR of 7.88% during the next five years. That growth will come from all sectors, including convenience store sales, e-commerce orders and the hospitality sector, which is recovering from COVID-19 slowdowns. Bottled water continues to be America’s favorite drink, outselling soda for the first time in 2016 and continuing that feat every year since. Leading the healthy beverage charge are companies, such as The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) (Profile), that are eager to innovate as they meet consumers calls for both taste and quality. In the most recent of a string of innovations that have earned WTER the title of largest independent alkaline company in the country, The Alkaline Water Company launched a brand new line of six natural functional waters. Earlier this year, Shaquille O’Neal, NBA Hall of Famer and Papa John’s International (NASDAQ: PZZA) board member, endorsed the company and was named an advisory board member. Other companies looking to innovate and grow in the space include Celsius Holdings Inc. (NASDAQ: CELH), Nestle SA ADR (OTC: NSRGY) and Keurig Dr Pepper Inc. (NASDAQ: KDP).

As consumers continue to insist on more healthy options in choices in their lives, the global health drinks market is projected to see consistent, continued growth, with a CAGR of 7.88% during the next five years. That growth will come from all sectors, including convenience store sales, e-commerce orders and the hospitality sector, which is recovering from COVID-19 slowdowns. Bottled water continues to be America’s favorite drink, outselling soda for the first time in 2016 and continuing that feat every year since. Leading the healthy beverage charge are companies, such as The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) (Profile), that are eager to innovate as they meet consumers calls for both taste and quality. In the most recent of a string of innovations that have earned WTER the title of largest independent alkaline company in the country, The Alkaline Water Company launched a brand new line of six natural functional waters. Earlier this year, Shaquille O’Neal, NBA Hall of Famer and Papa John’s International (NASDAQ: PZZA) board member, endorsed the company and was named an advisory board member. Other companies looking to innovate and grow in the space include Celsius Holdings Inc. (NASDAQ: CELH), Nestle SA ADR (OTC: NSRGY) and Keurig Dr Pepper Inc. (NASDAQ: KDP).

When Democrats took control of Capitol Hill during the elections in November 2020, there was growing optimism that federal legalization of cannabis was in the cards for Americans. Nine months into the new administration, progress has been slow in the United States. Latin American (“LATAM”) countries, on the other hand, have moved forward with new laws ending cannabis prohibition and supporting the industry, moves to generate government revenue, cut into illicit sales and bring novel therapeutic options to people in need. Colombia, Mexico and Panama are emerging as global pioneers promoting responsible cannabis commerce, which bodes well for Flora Growth Corp. (NASDAQ: FLGC) (Profile), a company with robust operations in Colombia. These countries are following the example set forth by Canada, which has given rise to some of the legal cannabis’ juggernauts, such as Canopy Growth Corporation (NASDAQ: CGC), Tilray Inc. (NASDAQ: TLRY) and Sundial Growers Inc. (NASDAQ: SNDL), as other companies such as Innovative Industrial Properties Inc. (NYSE: IIPR) lend additional support to the growing market.

As part of the reopening economy, investors should be monitoring several trends in the healthcare space, including several that fall in the “natural wellness” or “natural alternatives” categories.  The COVID-19 pandemic shone a bright light on lifestyle and self-care as people were encouraged, and often mandated, to stay at home. The trend further points to the next phase of cannabis market maturation, dubbed cannabis 3.0, against the backdrop of legislators discussing the Cannabis Administration and Opportunity Act that would create a national market for marijuana. Looking to address this opportunity, BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) (Profile) has been expanding and diversifying its business in 2021 from its core business as a high-capacity cannabis beverage company into a diversified health and wellness company through a number of accretive acquisitions. BevCanna is emerging as a leader among a group of companies, including the Valens Company (TSX: VLNS) (OTCQX: VLNCF), Neptune Wellness Solutions Inc. (NASDAQ: NEPT), NewAge Inc. (NASDAQ: NBEV) and AYR Wellness Inc. (CSE: AYR.A) (OTCQX: AYRWF), that are innovating and taking aggressive approaches to capitalize on the growing cannabis consumer trend moving toward a more wholistic wellness lifestyle business.

As part of the reopening economy, investors should be monitoring several trends in the healthcare space, including several that fall in the “natural wellness” or “natural alternatives” categories.  The COVID-19 pandemic shone a bright light on lifestyle and self-care as people were encouraged, and often mandated, to stay at home. The trend further points to the next phase of cannabis market maturation, dubbed cannabis 3.0, against the backdrop of legislators discussing the Cannabis Administration and Opportunity Act that would create a national market for marijuana. Looking to address this opportunity, BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) (Profile) has been expanding and diversifying its business in 2021 from its core business as a high-capacity cannabis beverage company into a diversified health and wellness company through a number of accretive acquisitions. BevCanna is emerging as a leader among a group of companies, including the Valens Company (TSX: VLNS) (OTCQX: VLNCF), Neptune Wellness Solutions Inc. (NASDAQ: NEPT), NewAge Inc. (NASDAQ: NBEV) and AYR Wellness Inc. (CSE: AYR.A) (OTCQX: AYRWF), that are innovating and taking aggressive approaches to capitalize on the growing cannabis consumer trend moving toward a more wholistic wellness lifestyle business.

When Democrats took control of Capitol Hill during the elections in November 2020, there was growing optimism that federal legalization of cannabis was in the cards for Americans. Nine months into the new administration, progress has been slow in the United States. Latin American (“LATAM”) countries, on the other hand, have moved forward with new laws ending cannabis prohibition and supporting the industry, moves to generate government revenue, cut into illicit sales and bring novel therapeutic options to people in need. Colombia, Mexico and Panama are emerging as global pioneers promoting responsible cannabis commerce, which bodes well for Flora Growth Corp. (NASDAQ: FLGC) (Profile), a company with robust operations in Colombia. These countries are following the example set forth by Canada, which has given rise to some of the legal cannabis’ juggernauts, such as Canopy Growth Corporation (NASDAQ: CGC), Tilray Inc. (NASDAQ: TLRY) and Sundial Growers Inc. (NASDAQ: SNDL), as other companies such as Innovative Industrial Properties Inc. (NYSE: IIPR) lend additional support to the growing market.

The emergence of psychedelic therapies as a popular investment a few years ago was mostly underscored by investors that rode the cannabis wave seeing a brand-new opportunity with drugs such as psilocybin, LSD, MDMA, DMT, and others to address hard-to-treat mental health diseases, namely depression, addiction, post-traumatic stress disorder and anxiety. As strides are being made on those fronts, a second investment wave is swelling on the horizon that looks to feature expanded indications and bring new therapeutic options to diseases with unmet needs. Psychedelics could redefine standards of care for chronic diseases and reshape psychiatry, including counseling practices, among other things. Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) (Profile) is leading this next wave of psychedelic drug development beyond mental health into chronic pain and eating disorders as the company advances its clinical programs. With a diverse approach, Tryp is joined by a short list of brand name leaders in psychedelics that includes ATAI Life Sciences N.V. (NASDAQ: ATAI), COMPASS Pathways Plc (NASDAQ: CMPS), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) and Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), all of which are making significant strides towards validating the legitimate potential of a wide range of psychedelic-based treatment regimens.

The emergence of psychedelic therapies as a popular investment a few years ago was mostly underscored by investors that rode the cannabis wave seeing a brand-new opportunity with drugs such as psilocybin, LSD, MDMA, DMT, and others to address hard-to-treat mental health diseases, namely depression, addiction, post-traumatic stress disorder and anxiety. As strides are being made on those fronts, a second investment wave is swelling on the horizon that looks to feature expanded indications and bring new therapeutic options to diseases with unmet needs. Psychedelics could redefine standards of care for chronic diseases and reshape psychiatry, including counseling practices, among other things. Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) (Profile) is leading this next wave of psychedelic drug development beyond mental health into chronic pain and eating disorders as the company advances its clinical programs. With a diverse approach, Tryp is joined by a short list of brand name leaders in psychedelics that includes ATAI Life Sciences N.V. (NASDAQ: ATAI), COMPASS Pathways Plc (NASDAQ: CMPS), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) and Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), all of which are making significant strides towards validating the legitimate potential of a wide range of psychedelic-based treatment regimens.

DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF), a digital asset investment firm bridging the gap between traditional capital markets and decentralized finance, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers DeFi Technologies subsidiary Valour Inc.’s recent announcement of imminent listings of its Exchange Traded Products (“ETPs”) on the Frankfurt Stock Exchange, which is the world's 12th largest stock exchange by market capitalization and the largest of the seven regional securities exchanges in Germany.

To hear the audio production, visit: https://www.nnw.fm/taiwk

To read the original press release, visit: https://nnw.fm/jQrdn

DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF), a digital asset investment firm bridging the gap between traditional capital markets and decentralized finance, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers DeFi Technologies subsidiary Valour Inc.’s recent announcement of imminent listings of its Exchange Traded Products (“ETPs”) on the Frankfurt Stock Exchange, which is the world's 12th largest stock exchange by market capitalization and the largest of the seven regional securities exchanges in Germany.

To hear the audio production, visit: https://www.nnw.fm/taiwk

To read the original press release, visit: https://nnw.fm/jQrdn

Exorbitant costs underscored by byzantine processes plague today’s healthcare systems, creating an $8.45 trillion global healthcare market in 2018, which represents about 10% of GDP in developed countries. Safe to say, the industry is looking for solutions, particularly more efficient ones that improve health outcomes and lower direct and indirect costs. The answer is found in technology, with healthtech (healthcare technology) and medtech (medical technology) buzzwords speaking to leveraging next-generation innovation in a bid to flatten the healthcare spending curve. New applications are being launched daily, and uptake is accelerating, fanned by the COVID-19 pandemic that bolstered adoption of self-diagnostic and remote solutions that have been embraced by health insurers and individuals alike. Some companies, such as Nemaura Medical Inc. (NASDAQ: NMRD) (Profile), are specializing in certain areas of unmet medical need, such as diabetes and obesity for NMRD. Others, including some of the most recognized names in the world such as Tesla Inc. (NASDAQ: TSLA), Apple Inc. (NASDAQ: AAPL), Garmin Ltd. (NASDAQ: GRMN) and Amazon.com Inc. (NASDAQ: AMZN), demonstrate the tremendous opportunity at hand for investments in new technologies and healthtech.

Exorbitant costs underscored by byzantine processes plague today’s healthcare systems, creating an $8.45 trillion global healthcare market in 2018, which represents about 10% of GDP in developed countries. Safe to say, the industry is looking for solutions, particularly more efficient ones that improve health outcomes and lower direct and indirect costs. The answer is found in technology, with healthtech (healthcare technology) and medtech (medical technology) buzzwords speaking to leveraging next-generation innovation in a bid to flatten the healthcare spending curve. New applications are being launched daily, and uptake is accelerating, fanned by the COVID-19 pandemic that bolstered adoption of self-diagnostic and remote solutions that have been embraced by health insurers and individuals alike. Some companies, such as Nemaura Medical Inc. (NASDAQ: NMRD) (Profile), are specializing in certain areas of unmet medical need, such as diabetes and obesity for NMRD. Others, including some of the most recognized names in the world such as Tesla Inc. (NASDAQ: TSLA), Apple Inc. (NASDAQ: AAPL), Garmin Ltd. (NASDAQ: GRMN) and Amazon.com Inc. (NASDAQ: AMZN), demonstrate the tremendous opportunity at hand for investments in new technologies and healthtech.

Look a little closer, and it’s clear that the world has entered a major global inflection point in the modern history of digital media. This new era of digital media is set to reshape the future of social fabric and revolutionize how brands connect with their consumers. The increasing innovation and intelligence in digital media tactics and strategies is making consumer messaging amazingly native and relevant. This personable approach  to online consumer targeting is providing ways to better serve brands by connecting to current and potential target consumers while cutting through the noise. As recently as 2019, mobile surpassed television on total time spent, and digital media has since rocketed past traditional media and advertising tactics. In fact many of the more established digital market tactics have become antiquated. Email marketing is dead, and traditional web banner ads are on life support. Brands understand that it takes more than a flash ad or a quick plug to inspire consumers. Enter the AI-driven martech and digital media software solutions market where innovative content, measurement and distribution solutions reside in all-encompassing marketing strategies engaging and communicating with target audiences through next-generation technology like that of DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) (Profile) to win and keep consumers’ interest and loyalty. The rapid evolution of the marketplace often benefits smaller companies such as DGTL, IZEA Worldwide Inc. (NASDAQ: IZEA), The Trade Desk (NASDAQ: TTD), Acuity Ads Holdings Inc. (TSX: AT) and EQ Inc. (TSX.V: EQ), as they can be more nimble and generally innovative compared to international CRM juggernauts in helping brands reach their objectives.

Look a little closer, and it’s clear that the world has entered a major global inflection point in the modern history of digital media. This new era of digital media is set to reshape the future of social fabric and revolutionize how brands connect with their consumers. The increasing innovation and intelligence in digital media tactics and strategies is making consumer messaging amazingly native and relevant. This personable approach  to online consumer targeting is providing ways to better serve brands by connecting to current and potential target consumers while cutting through the noise. As recently as 2019, mobile surpassed television on total time spent, and digital media has since rocketed past traditional media and advertising tactics. In fact many of the more established digital market tactics have become antiquated. Email marketing is dead, and traditional web banner ads are on life support. Brands understand that it takes more than a flash ad or a quick plug to inspire consumers. Enter the AI-driven martech and digital media software solutions market where innovative content, measurement and distribution solutions reside in all-encompassing marketing strategies engaging and communicating with target audiences through next-generation technology like that of DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) (Profile) to win and keep consumers’ interest and loyalty. The rapid evolution of the marketplace often benefits smaller companies such as DGTL, IZEA Worldwide Inc. (NASDAQ: IZEA), The Trade Desk (NASDAQ: TTD), Acuity Ads Holdings Inc. (TSX: AT) and EQ Inc. (TSX.V: EQ), as they can be more nimble and generally innovative compared to international CRM juggernauts in helping brands reach their objectives.

Hypertension, or high blood pressure, is rampant in America. An estimated 45% of adults in the United States, or 108 million people, have hypertension, yet only about one out of every four have their condition under control. That’s a big problem considering hypertension increases risks for heart disease and stroke, which are, respectively, the no. 1 and no. 5 leading causes of death in the nation each year. To that point, the CDC names hypertension as a primary or contributing cause in nearly half a million deaths annually in the U.S. Hypertension treatment options vary tremendously from meditation to conventional drugs, with what looks to be a promising new innovation on the horizon from Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile). Lexaria is proving that its proprietary DehydraTECH(TM) technology repeatedly delivers strong therapeutic responses, without the side effects of today’s drugs. Lexaria is looking to throw its hat into the ring with majors in the market today that are making billions of dollars by treating high blood pressure and other leading causes of death, including Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), AstraZeneca PLC (NASDAQ: AZN) and Moderna Inc. (NASDAQ: MRNA).

Hypertension, or high blood pressure, is rampant in America. An estimated 45% of adults in the United States, or 108 million people, have hypertension, yet only about one out of every four have their condition under control. That’s a big problem considering hypertension increases risks for heart disease and stroke, which are, respectively, the no. 1 and no. 5 leading causes of death in the nation each year. To that point, the CDC names hypertension as a primary or contributing cause in nearly half a million deaths annually in the U.S. Hypertension treatment options vary tremendously from meditation to conventional drugs, with what looks to be a promising new innovation on the horizon from Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile). Lexaria is proving that its proprietary DehydraTECH(TM) technology repeatedly delivers strong therapeutic responses, without the side effects of today’s drugs. Lexaria is looking to throw its hat into the ring with majors in the market today that are making billions of dollars by treating high blood pressure and other leading causes of death, including Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), AstraZeneca PLC (NASDAQ: AZN) and Moderna Inc. (NASDAQ: MRNA).

FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (“FuelPositive” or the “Company”) has hired engineer Dr. Ghassan Chehade, one of the co-inventors named on the provisional patent of the Company’s technology that will produce carbon-free ammonia (“NH3”). Dr. Chehade worked with Dr. Ibrahim Dincer on the original development of the Company’s core NH3 technology. He has joined the Company as Lead Project Engineer.

To view the full press release, visit https://nnw.fm/PSd7q

FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (“FuelPositive” or the “Company”) has hired engineer Dr. Ghassan Chehade, one of the co-inventors named on the provisional patent of the Company’s technology that will produce carbon-free ammonia (“NH3”). Dr. Chehade worked with Dr. Ibrahim Dincer on the original development of the Company’s core NH3 technology. He has joined the Company as Lead Project Engineer.

To view the full press release, visit https://nnw.fm/PSd7q

Canada produces sufficient green electricity in off-peak demand hours to produce enough carbon-free ammonia (“NH3”) to replace the use of fossil fuels for 100% of the passenger and freight aviation and rail, passenger bus, freight trucking, freight rail and freight marine shipping in the country, according to a study commissioned by FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (“FuelPositive” or the “Company”). If all carbon-free ammonia were used, the result would be a 15.3% reduction in Canada’s total greenhouse gas emissions. [Link to study summary: https://ml.globenewswire.com/Resource/Download/5ee10c6a-ba72-409f-bc0c-be756681fae9]

To view the full press release, visit https://nnw.fm/Yvz2e

Canada produces sufficient green electricity in off-peak demand hours to produce enough carbon-free ammonia (“NH3”) to replace the use of fossil fuels for 100% of the passenger and freight aviation and rail, passenger bus, freight trucking, freight rail and freight marine shipping in the country, according to a study commissioned by FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (“FuelPositive” or the “Company”). If all carbon-free ammonia were used, the result would be a 15.3% reduction in Canada’s total greenhouse gas emissions. [Link to study summary: https://ml.globenewswire.com/Resource/Download/5ee10c6a-ba72-409f-bc0c-be756681fae9]

To view the full press release, visit https://nnw.fm/Yvz2e